We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.

Hot Flashes · 7 min read

Non-hormonal hot flash treatment: what actually works

Published April 15, 2026 · Last updated May 10, 2026

For women who can't — or prefer not to — use hormone therapy, evidence-based non-hormonal options exist. Here is what the research supports.

Hot flashes — clinically called vasomotor symptoms (VMS) — are the most common symptom of the menopause transition. Hormone therapy is the most effective treatment, but it is not the right choice for everyone. Women with a history of hormone-sensitive breast cancer, blood clots, or stroke may have contraindications, and others simply prefer to avoid hormones. The good news: evidence-based non-hormonal options are better than they have ever been.

FDA-approved non-hormonal medications

Two medications are specifically FDA-approved for moderate-to-severe hot flashes. Low-dose paroxetine (Brisdelle, 7.5 mg) is an SSRI that modulates the brain chemistry involved in temperature regulation. Other SSRIs and SNRIs such as venlafaxine are also commonly used off-label with strong support from NAMS and ACOG.

In 2023, the FDA approved fezolinetant (Veozah) — a first-in-class neurokinin B (NKB) receptor antagonist. As estrogen falls during menopause, NKB activity rises and disrupts the brain's thermostat. Fezolinetant blocks that pathway directly and meaningfully reduces both the frequency and severity of moderate-to-severe hot flashes.

Off-label prescription options

  • Gabapentin — originally for seizures and nerve pain, reduces hot flash frequency by roughly 50% in trials; often taken at bedtime since drowsiness can help night sweats
  • Clonidine — a blood pressure medication with modest VMS effect, available as a daily pill or weekly patch; side effects include dizziness and dry mouth
  • Oxybutynin — used at low dose for VMS in some patients, particularly when sweating is the dominant complaint

Mind-body approaches with real evidence

The 2023 NAMS Nonhormone Therapy Position Statement specifically endorses cognitive behavioral therapy (CBT) and clinical hypnosis for hot flashes. CBT does not necessarily reduce the number of hot flashes but reliably reduces how bothersome they feel — which is what most women actually care about. Clinical hypnosis, performed by a trained clinician, has been shown in multiple trials to reduce both frequency and severity.

Lifestyle adjustments that move the needle

  • Identify and avoid personal triggers — most commonly alcohol, caffeine, spicy food, and acute stress
  • Dress in breathable layers; keep a fan at your desk and bedside
  • Aim for a healthy weight — higher BMI is associated with more frequent and severe hot flashes
  • Protect sleep aggressively; sleep loss amplifies VMS in every study

A note on supplements

Black cohosh, soy isoflavones, red clover, and dong quai are widely marketed for menopause relief, but the evidence is weak, mixed, or inconclusive. Supplements are not FDA-regulated the way prescription drugs are, so purity and potency are not guaranteed, and several can interact with other medications. Always discuss any supplement with your clinician before starting.

The bottom line

You have more proven non-hormonal hot flash options than ever before — and you do not have to simply power through. The right choice depends on your medical history, symptom severity, and personal preferences. A clinician trained in menopause medicine can help you build a personalized plan.

Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team (physician-supervised)
NPI 1609792902 · Last reviewed: July 3, 2026

More on hot flashes & night sweats

Sources

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Cardiovascular Health

The silent threat: why hypertension rises sharply in women after menopause

After menopause, women's blood pressure catches up to — and often surpasses — men's. Yet hypertension in midlife women is underdiagnosed and undertreated. Here is what every woman over 45 should know.

Perimenopause

Ovarian aging begins long before menopause: what new research means for women in their 30s and 40s

A new study shows ovaries display molecular signs of aging — inflammation, fibrosis, senescence — years before the final period. Here is why that changes how we should think about perimenopause care.

Symptoms

Frozen Shoulder and Perimenopause: The Symptom Penélope Cruz and Olivia Wilde Just Put on the Map

Frozen shoulder (adhesive capsulitis) is a painful, progressive loss of shoulder motion that peaks in women aged 40–60 — the same window as perimenopause. Declining estrogen appears to affect collagen, joint lubrication, and inflammation, which researchers believe may help explain the link.

Talk to a kindr physician

Board-certified review within 24 hours.

Start your visit →
Ask Dot